Facetten
Zugriff
Einrichtung
Medientyp
- Text 5
Karte
Erscheinungsjahr
Autor/in
- Augustin, Matthias
- Blauvelt, Andrew
- Lebwohl, Mark 2
- Papp, Kim A 2
- Puig, Lluís 2
- alle zeigen
Sprache
- Englisch 5
5 Einträge gefunden
-
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)
- Blauvelt, Andrew
- Kimball, Alexa B
- Augustin, Matthias
- Okubo, Yukari
- Witte, Michael M
- Capriles, Claudia Rodriguez
- Sontag, Angelina
-
Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: Results Through 48 Weeks of a Phase 3, Multicenter, Randomized, Double-Blinded, Etanercept- and Placebo-Controlled Study (CIMPACT)
- Lebwohl, Mark
- Blauvelt, Andrew
- Paul, Carle
- Sofen, Howard
- Węgłowska, Jolanta
- Piguet, Vincent
- Burge, Daniel
-
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- Gordon, Kenneth B
- Strober, Bruce
- Lebwohl, Mark
- Augustin, Matthias
- Blauvelt, Andrew
- Poulin, Yves
- Papp, Kim A
-
-
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders. A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
- Blauvelt, Andrew
- Papp, Kim A
- Griffiths, Christopher E M
- Puig, Luis
- Weisman, Jamie
- Dutronc, Yves
- Kerr, Lisa Farmer